The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 304.00
Bid: 303.00
Ask: 305.00
Change: 8.00 (2.70%)
Spread: 2.00 (0.66%)
Open: 306.00
High: 310.00
Low: 303.00
Prev. Close: 296.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Cordiant deploys IPO funds; Scotgold gets loan

Tue, 04th May 2021 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Cordiant Digital Infrastructure Ltd - investment firm focused on digital infrastructure assets - Announces deployment or commitment of substantially all of the net proceeds from its IPO into digital infrastructure platforms in the Czech Republic and Norway. Company has completed the acquisition of Ceske Radiokomunikace and entered into a legally binding letter of intent to acquire a Norwegian fibre network and certain land for data centre development for a combined total consideration of GBP451 million, comprising GBP318 million of equity and the assumption of an amount equal to GBP133 million of debt. Adds it has raised its dividend guidance, now targeting "no less than 3 pence per share" for the current financial year, up from 1p. Firm floated in London in February.

----------

Hutchmed (China) Ltd - Hong-Kong-based pharmaceutical company - Completes rolling submission of a new drug application to the US FDA for surufatinib for the treatment of pancreatic and extra-pancreatic neuroendocrine tumors. "Having successfully launched surufatinib in China early this year, we are now looking forward, subject to its approval, to being able to provide access to this important new therapeutic option for NETs patients in the US and beyond," says Marek Kania, managing director & chief medical officer of Hutchmed International Corp.

----------

AfriTin Mining Ltd - tin miner with asset in Namibia - Says definitive feasibility study confirms the feasibility of expanding the current phase 1 processing plant, resulting in a 67% increase in tin concentrate production to 1,200 tonnes per year from 720 tonnes. "The DFS confirms the highly attractive economics from a low-cost modular expansion of the current phase 1 at Uis which can be implemented in eight months. The DFS also coincides with the company achieving its first full quarter of steady state production at the phase 1 plant as a global tin prices reach a 10-year high," says Chief Executive Anthony Viljoen.

----------

SDX Energy PLC - London-headquartered oil and gas exploration, production, and development company - Starts the first phase of its 2021 drilling campaign in Morocco, which will comprise up to five wells over the year. The first phase will consist of three appraisal/development wells. The second phase of the Moroccan drilling campaign will commence in the autumn.

----------

Intelligent Ultrasound Group PLC - Cardiff, Wales-based artificial intelligence ultrasound software firm - Successfully registers with the MHRA to market ScanNav Anatomy: Peripheral Nerve Block in the UK and will be launching the product into the UK market at the forthcoming RA-UK annual scientific meeting. Continues to progress regulatory filing with US Food & Drug Administration, as well as seeking to licence an integrated version of the product to major ultrasound manufacturers. "ScanNav PNB uses the latest AI technology to automatically highlight the live ultrasound image to enhance the accuracy and standardisation of ultrasound image interpretation, by making it easier to identify key anatomical structures," company explains.

----------

CAP-XX Ltd - Australia-based supercapacitors and energy management systems manufacturer - Says Jack, developer of the first windshield breakage detection solution, has selected the CAP-XX HS208F supercap for its solar-powered Internet-of-Things device. "We are proud to provide the high energy and power density Jack needs to power its advanced communication system," said Anthony Kongats, chief executive at CAP-XX. "This is just one of the many possible applications for thin CAP-XX supercapacitors in IoT devices."

----------

Panther Metals PLC - company focused on mineral exploration in Canada and Australia - Receives new exploration permit to proceed with the revised plans for reconnaissance diamond drilling, ground induced polarisation geophysics and trenching focussed on testing intrusive contact shear-zone hosted gold mineralisation in the vicinity of the north shore of Dotted Lake. The new permit will allow Panther to drill up to 8 diamond drill holes this season where initial results warrant. The new permit extends these exploration permissions for three years to April 26, 2024. "This receipt now facilitates us to move our revised plans forward and we are currently engaging with potential contractors with a view to drill at the earliest opportunity," says Chief Executive Darren Hazelwood.

----------

Tribal Group PLC - provider of education software and services - Has acquired and paid for the remaining issued share capital of Semestry Limited, a supplier of cloud based scheduling and timetabling software to the higher education market. "Semestry has traded in line with expectations since the acquisition and the integration is progressing to plan," says Tribal.

----------

Secured Income Fund PLC - investor focused on SME loan assets and secured lending opportunities - Will return GBP3.7 million to shareholders via a second return of capital by the issue of B shares. Proceeds from the redemption of the B shares is equivalent to 7.0p per ordinary share, firm says. Capital being returned represents around 11% of company's net asset value as at end of March.

----------

Power Metal Resources PLC - metal exploration and development company - Establishes new 100%-owned and subsidiary 'incubator' business, Power Capital Investments Ltd, which will be initially be fully funded by the company. "Power Capital will actively identify small, entrepreneurial business ventures with significant growth potential in the junior resource space and provide support with regard to business management, project development and corporate development to enable them to scale rapidly and realise their potential. Power Capital may also provide financial support," Power Metal Resources explains.

----------

Scotgold Resources Ltd - gold exploration and production company focused on Scotland - Gets short-term loan of GBP2 million from group comprising Non-Executive Chair Nathaniel le Roux; non-executive directors Bill Styslinger, Peter Hetherington and Ian Proctor; and an unrelated third party. Loan provided to SGZ Cononish Ltd, a wholly-owned subsidiary of Scotgold.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
5 Apr 2024 11:54

Hutchmed China to make several presentations at cancer research meeting

(Sharecast News) - Hutchmed China announced the upcoming presentation of new and updated data from various studies featuring compounds it had discovered on Friday, at the American Association of Cancer Research (AACR) annual meeting from 5 to 10 April in San Diego, California.

Read more
2 Apr 2024 12:11

Hutchmed endometrial cancer treatment gets priority review in China

(Sharecast News) - Hutchmed China announced the acceptance and granting of priority review by the China National Medical Products Administration (NMPA) for a new drug application combining fruquintinib and sintilimab for the treatment of advanced endometrial cancer on Tuesday.

Read more
2 Apr 2024 10:32

Hutchmed endometrial cancer treatment application accepted for review

(Alliance News) - Hutchmed (China) Ltd on Tuesday jointly announced with Innovent Biologics that their new drug application for the combined fruquintinib and sintilimab treatment for endometrial cancer has been granted priority review by the China National Medical Products Administration.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
28 Mar 2024 13:02

Hutchmed cancer treatment indication accepted for review in China

(Sharecast News) - Hutchmed China announced a significant milestone in its cancer treatment work on Thursday, with the supplemental new drug application (sNDA) for savolitinib had been accepted for review by the China National Medical Products Administration (NMPA).

Read more
28 Mar 2024 11:08

Hutchmed lung cancer treatment accepted for review in China

(Alliance News) - Hutchmed (China) Ltd on Thursday said its supplemental new drug application for savolitinib has been accepted for review by the China National Medical Products Administration.

Read more
28 Mar 2024 08:08

LONDON BRIEFING: JD Sports backs outlook; Spirent accepts new offer

(Alliance News) - Stocks in London traded higher early on Thursday in the final trading day of a holiday-shortened week, despite some hawkish words from a US central banker.

Read more
22 Mar 2024 10:09

Hutchmed begins registration stage for sovleplenib phase 2/3 trial

(Alliance News) - Hutchmed (China) Ltd on Friday said it initiated the registration stage of the phase 2/3 clinical trial for sovleplenib, its warm antibody autoimmune hemolytic anemia treatment.

Read more
28 Feb 2024 17:31

EARNINGS: Hutchmed revenue surges, Craven House's loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
21 Feb 2024 15:14

UK earnings, trading statements calendar - next 7 days

Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
Friday 23 February 
City of London Investment Group PLCHalf Year Results
Irish Residential Properties REIT PLCFull Year Results
Standard Chartered PLCFull Year Results
Monday 26 February 
Base Resources LtdHalf Year Results
Bunzl PLCFull Year Results
EnSilica PLCHalf Year Results
Kosmos Energy LtdFull Year Results
Made Tech Group PLCHalf Year Results
Tristel PLCHalf Year Results
Tuesday 27 February 
abrdn Equity Income Trust PLCFull Year Results
abrdn PLCFull Year Results
Croda International PLCFull Year Results
Kitwave Group PLCFull Year Results
McBride PLCHalf Year Results
PCI-PAL PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Synectics PLCFull Year Results
Uniphar PLCFull Year Results
Unite Group PLCFull Year Results
Wednesday 28 February 
AB Dynamics PLCTrading Statement
ASA International Group PLCTrading Statement
Aston Martin Lagonda Global Holdings PLCFull Year Results
Avingtrans PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Derwent London PLCFull Year Results
Glenveagh Properties PLCFull Year Results
Grit Real Estate Income Group LtdHalf Year Results
Hutchmed China LtdFull Year Results
International Personal Finance PLCFull Year Results
Just Eat Takeaway.com NVFull Year Results
Primary Health Properties PLCFull Year Results
Reckitt Benckiser Group PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
RHI Magnesita NVFull Year Results
St James's Place PLCFull Year Results
Taylor Wimpey PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
7 Feb 2024 09:50

Hutchmed hails fruquintinib trial results for gastric cancer treatment

(Alliance News) - Hutchmed (China) Ltd on Wednesday said phase three data for fruquintinib in combination with paclitaxel showed an improvement in overall survival for patients with gastric or gastroesophageal junction adenocarcinoma.

Read more
2 Feb 2024 09:52

Hutchmed says Inmagene exercises option to licence drug candidates

(Alliance News) - Hutchmed (China) Ltd on Friday said Inmagene Biopharmaceuticals Ltd has exercised options to licence two drug candidates as part of a strategic partnership.

Read more
2 Feb 2024 09:42

Hutchmed partner Inmagene exercises options over two drug candidates

(Sharecast News) - Hutchmed China announced on Friday that Inmagene Biopharmaceuticals has exercised options to licence two drug candidates, IMG-007 and IMG-004, as part of their strategic partnership.

Read more
30 Jan 2024 10:32

Hutchmed's 'Elunate' approved under new Hong Kong rules

(Sharecast News) - Hutchmed China announced the approval of its drug 'Elunate', or fruquintinib, by the Pharmacy and Poisons Board of Hong Kong on Tuesday, for the treatment of adult patients with previously treated metastatic colorectal cancer (CRC).

Read more
30 Jan 2024 09:20

Hutchmed celebrates cancer drug approval in hometown of Hong Kong

(Alliance News) - Hutchmed (China) Ltd on Tuesday touted progress in Hong Kong, after its oral therapy for metastatic colorectal cancer received marketing approval in the city.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.